OTC · Medical - Pharmaceuticals

Nutroganics, Inc. (NUTTQ) Stock

$0.00 OTC: NUTTQ Healthcare

Nutroganics, Inc.'s primary business strategy involved acquiring and overseeing profitable companies within the healthy lifestyle industry, focusing heavily on nutritional supplements and the natural and organic food markets. One of its key operational entities was Silverbow Honey Company, a subsidiary that handled the production, packaging, and sale of various honey products.

Valuation

MetricValue
Price$0.00
Market Cap$1.07M
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.10
EPS (TTM)$-0.16
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE150.00%
ROA-42.86%
ROCE-306.13%
Gross Margin-27.27%
Operating Margin-27.27%
Net Margin-27.27%
Debt/Equity-1.50
Current Ratio0.33

Annual Financials (USD)

Metric20002001200220032015
Revenue$15.0M$7.0M$6.0M$5.0M$11.0M
Operating Profit$-1.0M$-3.0M$0$0$-3.0M
Net Profit$0$-3.0M$0$0$-3.0M
EPS$-0.07$-0.45$0.00$-0.02$-0.16
Op Margin-3.7%-43.6%6.3%-0.5%-23.8%

Balance Sheet (USD)

Metric20002001200220032015
Total Assets$5.0M$2.0M$2.0M$2.0M$7.0M
Total Liabilities$2.0M$2.0M$2.0M$2.0M$9.0M
Cash$2.0M$0$1.0M$0$0
Borrowings$0$0$1.0M$1.0M$3.0M

Latest News

What does the China reset mean for the Nike business? Investing.com · Aug 1, 2026 Morgan Stanley's Amazon earnings verdict has a blind spot TheStreet · Aug 1, 2026 Video shows dramatic rescue after woman swept downstream in Kern River USA TODAY · Aug 1, 2026 Hershey Canada Voluntarily Recalls Certain Lots of Hershey's Kisses Creamy Milk Chocolate Candy Due to Potential for Undeclared Almonds CNW Group · Aug 1, 2026 Prediction: Eli Lilly Will Be Worth $2 Trillion by 2031 Motley Fool · Aug 1, 2026

Cash Flow (USD)

Metric20002001200220032015
Operating Cash Flow$-2.0M$-2.0M$0$0$0
Investing Cash Flow$0$-1.0M$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-2.0M$-1.0M$0$0$0
Free Cash Flow$-2.0M$-2.0M$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.87
FCF Yield-33.53%
Quick Ratio0.20
Interest Coverage0.00
Return 1Y
Return 3Y
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CNBIChina BCT Pharmacy Group, Inc. $0.00 0.00 $686778 0.00%
DIGPDigipath, Inc. $0.01 +4.00% -1.55 $1.09M 0.00%
ETRGFEntourage Health Corp. $0.00 -0.03 $1.23M 0.00%
GNOWAmerican Caresource Holdings, Inc. $0.00 0.00 $859731 0.00%
HTPRFHTC Purenergy Inc. $0.00 -0.08 $8153 0.00%

About Nutroganics, Inc.

Nutroganics, Inc.'s primary business strategy involved acquiring and overseeing profitable companies within the healthy lifestyle industry, focusing heavily on nutritional supplements and the natural and organic food markets. One of its key operational entities was Silverbow Honey Company, a subsidiary that handled the production, packaging, and sale of various honey products. These goods were supplied to food manufacturers and prominent national grocery chains, marketed under both the Silverbow brand and as private label offerings. The company was based in Bethesda, Maryland. However, a significant development occurred on October 14, 2016, when Nutroganics, Inc. and its affiliated organizations filed a voluntary petition for Chapter 7 liquidation with the US Bankruptcy Court for the District of Delaware.

Nutroganics, Inc. (NUTTQ) stock trades at $0.00 with a market capitalization of $1.07M. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.10. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Nutroganics, Inc. generates a return on equity (ROE) of 150.00% — well above the market average, a sign of a high-quality business, return on capital employed of -306.13%, an operating margin of -27.27%, a net profit margin of -27.27%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides